Abigail Jang

Abigail Jang is a highly experienced scientist specializing in strain engineering, currently serving as Project and Client Lead at 21st.BIO since October 2021. Prior to this role, Abigail held significant positions at Novozymes as a Project Leader in the Protein Expression Technology Department and at Monsanto Co as a Research Associate in a contract position. Abigail's earlier experience includes roles as a Buyer at JB3 Outdoors and as a Staff Research Associate II at the University of California. Abigail began their research career at deCODE Genetics as a Research Scientist II and has also worked at MediChem. Abigail Jang earned a degree from the University of Illinois Urbana-Champaign.